Loading…
Academic Journal
Teriflunomide in patients with multiple sclerosis
N. Y. Lasch, A. N. Boyko
Медицинский совет, Vol 0, Iss 5, Pp 90-93 (2015)
Saved in:
| Title | Teriflunomide in patients with multiple sclerosis |
|---|---|
| Authors | N. Y. Lasch, A. N. Boyko |
| Publication Year |
2015
|
| Source |
Медицинский совет, Vol 0, Iss 5, Pp 90-93 (2015)
|
| Description |
The article discusses the prospects for the use of the new drug teriflunomide for the treatment of patients with relapsing-remitting multiple sclerosis. By now, phase II and III clinical trials are completed which demonstrated good tolerability, efficacy and relative safety of teriflunomide. The TEMSO and TOWER trials showed a decrease in the incidence of relapse which was a reason for hospitalization (by 59 and 37%, respectively), as well as in the incidence of exacerbations requiring treatment with corticosteroids (by 34 and 36%, respectively).
|
| Document Type |
article
|
| Language |
Russian
|
| Publisher Information |
Remedium Group LLC, 2015.
|
| Subject Terms | |
